Prophylactic Antibiotics in Severe Alcohol-Related Hepatitis, Autotaxin Inhibitor Ziritaxestat for Idiopathic Pulmonary Fibrosis, Review of Cirrhosis, and more
Editor’s Summary by Anne Rentoumis Cappola, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the May 9, 2023, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - May 9, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Due to risk of serious liver injury, FDA restricts use of obeticholic acid (Ocaliva) in primary biliary cholangitis (PBC) patients with advanced cirrhosis
Listen to FDA Drug Safety Podcast on due to risk of serious liver injury, FDA restricts use of Ocaliva in primary biliary cholangitis (PBC) patients with advanced cirrhosis (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - June 3, 2021 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
JAMA Neurology : Cirrhosis and Stroke in a Nationally Representative Cohort
Interview with Hooman Kamel, MD, author of Association Between Cirrhosis and Stroke in a Nationally Representative Cohort (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 5, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Cirrhosis and Stroke in a Nationally Representative Cohort
Interview with Hooman Kamel, MD, author of Association Between Cirrhosis and Stroke in a Nationally Representative Cohort (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 5, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Cirrhosis and Stroke in a Nationally Representative Cohort (JAMA Neurology)
Interview with Hooman Kamel, MD, author of Association Between Cirrhosis and Stroke in a Nationally Representative Cohort (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 5, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Cirrhosis Paradox: Is the Risk for Clotting or for Bleeding?
Previously thought to be ' anticoagulated, ' patients with cirrhosis really might be hypercoagulable. Dr David Johnson explains why this paradox is a ' must understand ' for all who manage this condition. (Source: Medscape Gastroenterology Podcast)
Source: Medscape Gastroenterology Podcast - April 10, 2017 Category: Gastroenterology Authors: Medscape Source Type: podcasts
DCV/ASV/BCV for HCV Infection With Cirrhosis
Interview with Andrew J. Muir, MD, author of Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - May 5, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Using Transjugular Intrahepatic Portosystemic Shunts (TIPS) for Complications of Cirrhosis
A look at new information in the November issue of CGH concerning Transjugular Intrahepatic Portosystemic Shunts (TIPS) for complications of cirrhosis. Dr. Kuemmerle speaks to Dr. Arun Sanyal of Virginia Commonwealth University (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - November 2, 2011 Category: Gastroenterology Authors: AGA Source Type: podcasts
Immune Dysfunction and Infections in Patients with Cirrhosis
A review article in the September issue of CGH looks at the pathogenesis of infections and immune dysfunction in patients with cirrhosis. Dr. Kuemmerle speaks to author K. Rajender Reddy of the University of Pennsylvania Health System (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - September 1, 2011 Category: Gastroenterology Authors: AGA Source Type: podcasts
Prevalence of Primary Biliary Cirrhosis–Autoimmune Hepatitis Overlap Syndrome
A study in the July CGH looked to diagnose the primary biliary cirrhosis (PBC)–chronic autoimmune hepatitis (AIH) overlap syndrome and their level of overlap at a tertiary referral center. Dr. Kuemmerle speaks with Dr. Marshall M. Kaplan. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 6, 2011 Category: Gastroenterology Authors: AGA Source Type: podcasts
Prevalence of Primary Biliary Cirrhosis –Autoimmune Hepatitis Overlap Syndrome
A study in the July CGH looked to diagnose the primary biliary cirrhosis (PBC) –chronic autoimmune hepatitis (AIH) overlap syndrome and their level of overlap at a tertiary referral center. Dr. Kuemmerle speaks with Dr. Marshall M. Kaplan. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 6, 2011 Category: Gastroenterology Authors: AGA Source Type: podcasts
Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial
A study in the October 2010 CGH examines safety and complications of percutaneous liver biopsy in patients with hepatitis C–related bridging fibrosis or cirrhosis who were enrolled in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - October 5, 2010 Category: Gastroenterology Authors: AGA Source Type: podcasts
Quality Indicators in Care of Patients with Cirrhosis
Dr. Kuemmerle speaks with Dr. Bruce Bacon about a new set of quality indicators for treatment of patients with cirrhosis. Also, a new segment highlighting stories from the AGA newspaper, GI & Hepatology News (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - August 2, 2010 Category: Gastroenterology Authors: AGA Source Type: podcasts
